Compare ESPR & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESPR | TRVG |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.9M | 211.2M |
| IPO Year | 2013 | 2015 |
| Metric | ESPR | TRVG |
|---|---|---|
| Price | $2.04 | $2.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $8.75 | $4.09 |
| AVG Volume (30 Days) | ★ 6.5M | 26.7K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $403,135,000.00 | N/A |
| Revenue This Year | N/A | $15.59 |
| Revenue Next Year | $12.81 | $8.42 |
| P/E Ratio | ★ N/A | $16.98 |
| Revenue Growth | ★ 21.31 | N/A |
| 52 Week Low | $0.73 | $2.59 |
| 52 Week High | $4.18 | $5.83 |
| Indicator | ESPR | TRVG |
|---|---|---|
| Relative Strength Index (RSI) | 32.79 | 47.34 |
| Support Level | $1.02 | $2.74 |
| Resistance Level | $2.08 | $3.22 |
| Average True Range (ATR) | 0.20 | 0.10 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 1.14 | 43.24 |
Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.
trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.